These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 17619709

  • 21. Presence of Oxalobacter formigenes in the intestinal tract is associated with the absence of calcium oxalate urolith formation in dogs.
    Gnanandarajah JS, Abrahante JE, Lulich JP, Murtaugh MP.
    Urol Res; 2012 Oct; 40(5):467-73. PubMed ID: 22223029
    [Abstract] [Full Text] [Related]

  • 22. Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist.
    Daniel SL, Moradi L, Paiste H, Wood KD, Assimos DG, Holmes RP, Nazzal L, Hatch M, Knight J.
    Appl Environ Microbiol; 2021 Aug 26; 87(18):e0054421. PubMed ID: 34190610
    [Abstract] [Full Text] [Related]

  • 23. Sel1-like proteins and peptides are the major Oxalobacter formigenes-derived factors stimulating oxalate transport by human intestinal epithelial cells.
    Arvans D, Chang C, Alshaikh A, Tesar C, Babnigg G, Wolfgeher D, Kron S, Antonopoulos D, Bashir M, Cham C, Musch M, Chang E, Joachimiak A, Hassan H.
    Am J Physiol Cell Physiol; 2023 Jul 01; 325(1):C344-C361. PubMed ID: 37125773
    [Abstract] [Full Text] [Related]

  • 24. Development of an Innovative Method by Optimizing qPCR Technique for Isolating and Determining Oxalobacter Formigenes Microbial Load in the Stool of Patients with Urolithiasis.
    Jafari GA, Fotouhi Ardakani R, Akhavan Sepahi M, Nowroozi J, Soltanpour MS.
    Iran J Kidney Dis; 2021 May 01; 15(3):190-198. PubMed ID: 33994378
    [Abstract] [Full Text] [Related]

  • 25. Variability of Oxalobacter formigenes and oxalate in stool samples.
    Prokopovich S, Knight J, Assimos DG, Holmes RP.
    J Urol; 2007 Nov 01; 178(5):2186-90. PubMed ID: 17870112
    [Abstract] [Full Text] [Related]

  • 26. Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.
    Miller AW, Choy D, Penniston KL, Lange D.
    Kidney Int; 2019 Jul 01; 96(1):180-188. PubMed ID: 31130222
    [Abstract] [Full Text] [Related]

  • 27. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India.
    Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD.
    Eur Urol; 2002 Mar 01; 41(3):318-22. PubMed ID: 12180235
    [Abstract] [Full Text] [Related]

  • 28. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B, von Unruh G, Laube N, Hesse A, Sidhu H.
    Urol Res; 2005 Nov 01; 33(5):372-5. PubMed ID: 16284877
    [Abstract] [Full Text] [Related]

  • 29. New perspectives on an old grouping: The genomic and phenotypic variability of Oxalobacter formigenes and the implications for calcium oxalate stone prevention.
    Chmiel JA, Carr C, Stuivenberg GA, Venema R, Chanyi RM, Al KF, Giguere D, Say H, Akouris PP, Domínguez Romero SA, Kwong A, Tai V, Koval SF, Razvi H, Bjazevic J, Burton JP.
    Front Microbiol; 2022 Nov 01; 13():1011102. PubMed ID: 36620050
    [Abstract] [Full Text] [Related]

  • 30. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura N, Inagaki T, Hara I.
    Am J Kidney Dis; 2013 Jun 01; 61(6):923-9. PubMed ID: 23433467
    [Abstract] [Full Text] [Related]

  • 31. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria.
    Hoppe B, Leumann E, von Unruh G, Laube N, Hesse A.
    Front Biosci; 2003 Sep 01; 8():e437-43. PubMed ID: 12957811
    [Abstract] [Full Text] [Related]

  • 32. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
    Hoppe B, Dittlich K, Fehrenbach H, Plum G, Beck BB.
    Am J Kidney Dis; 2011 Sep 01; 58(3):453-5. PubMed ID: 21705122
    [Abstract] [Full Text] [Related]

  • 33. Oxalobacter formigenes and its potential role in human health.
    Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS.
    Appl Environ Microbiol; 2002 Aug 01; 68(8):3841-7. PubMed ID: 12147479
    [Abstract] [Full Text] [Related]

  • 34. Oxalobacter formigenes: A new hope as a live biotherapeutic agent in the management of calcium oxalate renal stones.
    Hiremath S, Viswanathan P.
    Anaerobe; 2022 Jun 01; 75():102572. PubMed ID: 35443224
    [Abstract] [Full Text] [Related]

  • 35. Oxalobacter formigenes Colonization and Oxalate Dynamics in a Mouse Model.
    Li X, Ellis ML, Knight J.
    Appl Environ Microbiol; 2015 Aug 01; 81(15):5048-54. PubMed ID: 25979889
    [Abstract] [Full Text] [Related]

  • 36. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease.
    Knight J, Deora R, Assimos DG, Holmes RP.
    Urolithiasis; 2013 Jun 01; 41(3):187-96. PubMed ID: 23632911
    [Abstract] [Full Text] [Related]

  • 37. [Oxalate: a poorly soluble organic waste with consequences].
    Lu Y, Bonny O.
    Praxis (Bern 1994); 2015 Mar 25; 104(7):353-9. PubMed ID: 25804778
    [Abstract] [Full Text] [Related]

  • 38. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C.
    Kidney Int; 2001 Sep 25; 60(3):1097-105. PubMed ID: 11532105
    [Abstract] [Full Text] [Related]

  • 39. Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition.
    Verhulst A, Dehmel B, Lindner E, Akerman ME, D'Haese PC.
    Urolithiasis; 2022 Apr 25; 50(2):119-130. PubMed ID: 35122487
    [Abstract] [Full Text] [Related]

  • 40. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn's Disease.
    Siener R, Ernsten C, Speller J, Scheurlen C, Sauerbruch T, Hesse A.
    Nutrients; 2024 Jan 16; 16(2):. PubMed ID: 38257157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.